| Date | Acquired company | Acquiring company | Amount | Related |
|---|---|---|---|---|
| 0000-00-00 | Vtesse (USA - MD) | Sucampo Pharmaceuticals (USA - MA) | $200 million | Rare diseases - Genetic diseases |
| 0000-00-00 | Universal Cells (USA - WA) | Astellas Pharma (Japan) | up to $102.5 million | Technology - Services - Regenerative Medicine |
